1 osition using a weighted Euclidean distance (
WED) approach.
2 Of 406 eligible survivors,
we approached 261 to participate and 213 consented.
3 As
we approach a "Full Earth" of over ten billion people wi
4 We approached a non-destructive method to evaluate LMC a
5 We approached all authors of included trials and request
6 rd generation of the Framingham Heart Study,
we approached all participants in 2009 to ask whether th
7 r necrosis factor inhibitors has changed how
we approach and manage autoimmune diseases.
8 th quantum mechanics and special relativity,
we approach another anniversary--that of Einstein's foun
9 sequencing (WGS), or whole exome sequencing (
WES) approach as the next powerful tool for relating gen
10 The second question
we approached by applying the same protocol to 22 health
11 unts of information that is transforming how
we approach cancer treatment and prevention.
12 We approached catestatin heritability using twin pairs,
13 determine whether a whole exome sequencing (
WES) approach could identify pathogenic-segregating vari
14 l guidelines and offer some insight into how
we approach current controversies in clinical management
15 The
WES approach described here does not require specialized
16 ate that this new framework might impact how
we approach disease mechanisms.
17 m how this saga unfolded are relevant to how
we approach drug surveillance and regulation, integrate
18 l will require fundamental change in the way
we approach energy production, and a number of environme
19 We approach estimating genome length by first estimating
20 ity to leprosy,while whole exome sequencing (
WES) approach has not yet been applied.
21 s of complex systems and will change the way
we approach human health and disease.
22 We approached mAb production in a different way and immu
23 aves the way for a paradigm shift in the way
we approach neurological disorders.
24 of calmodulin using the "weighted ensemble" (
WE) approach of Huber and Kim.
25 In this study, we used
WES approach on four leprosy patients and four healthy c
26 approaches has fundamentally changed the way
we approach problems in basic and translational research
27 The comparison indicates that the
WE approach quantitatively reproduces the brute-force re
28 The
WE approach runs an ensemble of parallel trajectories wi
29 urrent unsatisfactory outcomes may change as
we approach schizophrenia as a neurodevelopmental disord
30 We approach single compartment drug delivery from both a
31 Here,
we approach soaring flight as a problem of learning to n
32 We approach SRM from another direction: we focus on the
33 Here we describe a whole exome sequencing (
WES) approach that allows rapid and cost-effective ident
34 As
we approach the 100-year anniversary of that event, a cr
35 appears to be under a full head of steam as
we approach the 21st century.
36 In this contribution,
we approach the analysis from the perspective of profili
37 As
we approach the completed sequencing of 1,000 microbial
38 As
we approach the completion of the trypanosome genome pro
39 s with hypereosinophilia has changed the way
we approach the diagnosis and treatment of eosinophilic
40 has a great future in polio interruption as
we approach the endgame strategy for polio eradication.
41 e importance of considering the way in which
we approach the genotype-phenotype relationship.
42 In this study,
we approach the inhibition of HIV-1 replication by upreg
43 ntegrating a few (i.e., four) good features,
we approach the maximal predictive power of current geno
44 As
we approach the molecular era of oncology, future strate
45 As
we approach the next millenium it is clear that breast c
46 short-lived gases more expensive to emit as
we approach the prescribed ceiling.
47 We approach the problem by constructing statistics to te
48 We approach the problem by redesigning the anticancer dr
49 uscle contractions are naturally controlled,
we approach the problem of eliciting goal-directed limb
50 We approach the problem of neurological complications of
51 In this study,
we approach the problem of parameter estimation in condu
52 We approach the protein interactions by coimmunoprecipit
53 ake form of a bursty sequence of events once
we approach the semantically relevant topics of the text
54 on of adaptive immunity and consequently how
we approach the treatment of numerous immunologic disord
55 of the brain, especially during development,
we approached the consequences of MeCP2 deficiency in a
56 In this study
we approached the problem by combining static and dynami
57 We approached the question by taking advantage of the ex
58 Thus,
we approached the systems of the filamentous Anabaena sp
59 We approached the total cohort of medical and surgical n
60 We approach thermoelectric material design using the che
61 We approach these complex effects by a morphological ana
62 We approach these questions using selective substitution
63 We approached these problems by developing a classificat
64 We approached these questions by studying a possible lin
65 We approached these questions using a quantitative genet
66 We approach this by drawing on dynamical systems theory.
67 We approach this complex problem by assessing the contri
68 Here
we approach this goal by using an orthogonal high-throug
69 We approach this idea two ways.
70 We approach this issue by constructing an index of corre
71 We approach this issue in high-functioning males with au
72 In contrast to the MM,
we approach this issue through a Comprehensive Model (CM
73 As a follow-up to our previous work,
we approach this problem by considering the translocatio
74 We approach this problem by modelling the epithelium as
75 We approach this problem by seeking to determine, in an
76 In this work,
we approach this problem by using the largest assembled
77 We approach this puzzle from a reinforcement learning pe
78 We approach this question by making the corresponding su
79 We approach this question by using evolutionary game the
80 Here,
we approach this question from the perspective of gramma
81 We approach this question using lattice polymers as a co
82 We approached this by comparing the response of the andr
83 We approached this complex stochastic system using advan
84 We approached this goal with a synthetic DNA recombinati
85 We approached this hypothesis by studying such a polysac
86 We approached this issue by testing the ability of molec
87 We approached this issue in a relatively theory-neutral
88 We approached this problem by emphasizing affective and
89 We approached this problem by evaluating leaf stomatal d
90 We approached this problem by purifying capsids from Kap
91 We approached this problem by using a polymer poly(glyce
92 We approached this problem by using the fact that bacter
93 We approached this problem in zebrafish by combining ide
94 We approached this problem through an integrated applica
95 t match up with syntactic phrase boundaries,
we approached this problem with a word-chunking paradigm
96 We approached this question by analysis of binding of [3
97 We approached this question by analysis of cytochalasin
98 We approached this question by applying double-blind bih
99 We approached this question by challenging chimpanzees t
100 We approached this question by studying human infants' u
101 We approached this question by systematically deleting r
102 We approached this question from an immunological perspe
103 Here,
we approached this question in the context of lung cance
104 We approached this question using two complimentary anal
105 We approached this question with data from a large study
106 We approached this task by preparing nanoporous polymer
107 We approached this through the design, synthesis, and bi
108 nsion of brain function, a rethinking of how
we approach translational science, a focus on human neur
109 In the current study,
we approached tumor cell heterogeneity from the perspect
110 As
we approach two decades since the first identification o
111 l, this scaffold vaccine will change the way
we approached untreatable cancers, but more importantly,
112 sequencing (WGS) or whole-exome sequencing (
WES) approaches while the identification of genomic vari